Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Frank Adell
AddedMar 31, 2024
UpdatedMay 31, 2026
Frank Adell

Frank Adell

CEO, Cognos Therapeutics

CrunchbaseLinkedIn

Frank Adell's Career

Cognos Therapeutics
Cognos Therapeutics

Inglewood, CA, US

CEO· C-Suite · Management
Pharmaco-Kinesis
Pharmaco-Kinesis

Inglewood, CA, US

CEO· C-Suite · Management
Magnetecs
Magnetecs

Inglewood, CA, US

Co-Founder
Autonomous Medical Devices
Autonomous Medical Devices

Los Angeles, CA, US

Founder

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Frank Adell's Career

Cognos Therapeutics
Cognos Therapeutics
Series A$3.9M102003Inglewood, CA, US
CEO· C-Suite · Management

Similar to Cognos Therapeutics

CognoaCognoaPalo Alto, CA, USDigital Diagnostics, Therapeuticsest. 2013CognoaPalo Alto, CA, US · est. 2013

Cognoa, Inc.: Global provider of digital diagnostic and therapeutic healthcare solutions for children and families.

Series B · $127M77
Jan MedicalJan MedicalMountain View, CA, USMedical Devicesest. 2003Jan MedicalMountain View, CA, US · est. 2003

Developing medical devices to enhance brain disorder diagnostics and therapy acceleration.

Series C · $11M17
Neuro42Neuro42Oakland, CA, USMedical Devicesest. 2020Neuro42Oakland, CA, US · est. 2020

neuro42: Innovating advanced MRI tech for diagnosing and treating neurological conditions.

Series B · $12.8M26
Cognito TherapeuticsCognito TherapeuticsCambridge, MA, USAlzheimers Treatmentsest. 2016Cognito TherapeuticsCambridge, MA, US · est. 2016

Cognito Therapeutics: Non-invasive neuromodulation platform for Alzheimer's treatments.

Series B · $181.8M30
Pharmaco-Kinesis
Pharmaco-Kinesis
Pre-Seed$1.2M162006Inglewood, CA, US
CEO· C-Suite · Management

Leadership at Pharmaco-Kinesis

Eli GangEli GangCo-Founder

Similar to Pharmaco-Kinesis

Neuro-KinesisNeuro-KinesisInglewood, CA, USSurgical Toolsest. 2013Neuro-KinesisInglewood, CA, US · est. 2013

Neuro-Kinesis, a medical tech firm, innovates surgical tools with advanced biosensors for real-time biofeedback, enhancing patient outcomes.

Seed · $50k6
Neuro KineticsNeuro KineticsPittsburgh, PA, USMedical Instrumentsest. 1984Neuro KineticsPittsburgh, PA, US · est. 1984

Neuro Kinetics Inc: A leading manufacturer of medical and surgical instruments since 2002.

Angel · $1.3M32
Ortho KinematicsOrtho KinematicsAustin, TX, USMedical Devicesest. 2006Ortho KinematicsAustin, TX, US · est. 2006

Ortho Kinematics, Inc.: Innovating spine diagnostics with automated, functional motion analysis equipment.

Series D · $53.6M31
Quantrx BiomedicalQuantrx BiomedicalTualatin, OR, USMedical Devicesest. 1986Quantrx BiomedicalTualatin, OR, US · est. 1986

QuantRX Biomedical Corp: Innovating medical tech for diagnosis and treatment needs.

Public · $406M5
Magnetecs
Magnetecs
Acquired$16M02003Inglewood, CA, US
Co-Founder

Leadership at Magnetecs

Josh ShacharJosh ShacharCo-Founder
Autonomous Medical Devices
Autonomous Medical Devices
Pre-Seed$142.7M552013Los Angeles, CA, US
Founder

Leadership at Autonomous Medical Devices

David OkronglyDavid OkronglyCEO

Similar to Autonomous Medical Devices

Novel MicrodevicesNovel MicrodevicesBaltimore, MD, USMedical Devicesest. 2014Novel MicrodevicesBaltimore, MD, US · est. 2014

Novel Microdevices, LLC: A Maryland-based provider of innovative molecular diagnostic medical devices.

Pre-Seed · $19.6M14
AmydisAmydisSan Diego, CA, USPharmaceuticalsest. 2013AmydisSan Diego, CA, US · est. 2013

San Diego-based Amydis is a private pharma company innovating in amyloid protein disease detection.

Series A · $19.6M41
Advanced Medical Device TechnologiesAdvanced Medical Device TechnologiesNewport Beach, CA, USMedical Devicesest. 2019Advanced Medical Device TechnologiesNewport Beach, CA, US · est. 2019

Advanced Medical Device Technologies: Your trusted provider of innovative medical device designs.

Seed · $250k2
Neuro-KinesisNeuro-KinesisInglewood, CA, USSurgical Toolsest. 2013Neuro-KinesisInglewood, CA, US · est. 2013

Neuro-Kinesis, a medical tech firm, innovates surgical tools with advanced biosensors for real-time biofeedback, enhancing patient outcomes.

Seed · $50k6

Frank Adell's Similar Executives & Operators

Achmad ZakyAchmad ZakyCo-Founder · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakWillix HalimWillix HalimCEO · BukalapakBo ZhangBo ZhangCo-Founder · DiDiWILL WEI CHENGWILL WEI CHENGCo-Founder · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniFounder · Reliance RetailBrian KimBrian KimCo-Founder · KakaoKim Beom-sooKim Beom-sooCo-Founder · Kakao

People Similar to Frank Adell

Alec BellAlec BellCo-Founder · SensorSurfFrank LisFrank LisCEO · Kineticos VenturesGeorge BaloghGeorge BaloghCo-Founder · SpectrasensorsPeter S. FriedmanPeter S. FriedmanFounder · Integrated SensorsDave CoppsDave CoppsCo-Founder & CEO · Worlds